loading
Schlusskurs vom Vortag:
$44.95
Offen:
$44.55
24-Stunden-Volumen:
1.31M
Relative Volume:
0.66
Marktkapitalisierung:
$2.42B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-38.99M
KGV:
-15.05
EPS:
-2.9966
Netto-Cashflow:
$-24.94M
1W Leistung:
-8.72%
1M Leistung:
-32.80%
6M Leistung:
-38.46%
1J Leistung:
-17.43%
1-Tages-Spanne:
Value
$44.20
$46.97
1-Wochen-Bereich:
Value
$44.20
$49.46
52-Wochen-Spanne:
Value
$41.50
$90.32

Soleno Therapeutics Inc Stock (SLNO) Company Profile

Name
Firmenname
Soleno Therapeutics Inc
Name
Telefon
650-213-8444
Name
Adresse
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
Name
Mitarbeiter
152
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-05
Name
Neueste SEC-Einreichungen
Name
SLNO's Discussions on Twitter

Vergleichen Sie SLNO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
SLNO
Soleno Therapeutics Inc
45.11 2.41B 0 -38.99M -24.94M -2.9966
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.76 107.15B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
755.90 77.46B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
436.38 58.90B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
918.92 56.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
198.76 42.58B 447.02M -1.18B -906.14M -6.1812

Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-11-18 Eingeleitet Wolfe Research Outperform
2025-10-07 Eingeleitet Goldman Buy
2025-08-20 Eingeleitet Wells Fargo Overweight
2025-06-23 Eingeleitet TD Cowen Buy
2025-03-05 Fortgesetzt Stifel Buy
2024-12-02 Bestätigt Robert W. Baird Outperform
2024-12-02 Bestätigt Stifel Buy
2024-09-03 Eingeleitet H.C. Wainwright Buy
2024-05-10 Eingeleitet Robert W. Baird Outperform
2024-02-05 Eingeleitet Piper Sandler Overweight
2024-01-23 Eingeleitet Stifel Buy
2023-11-21 Fortgesetzt Guggenheim Buy
2020-09-29 Eingeleitet Guggenheim Buy
2020-01-10 Eingeleitet Craig Hallum Buy
2019-12-23 Eingeleitet Oppenheimer Outperform
2018-02-13 Bestätigt Maxim Group Buy
Alle ansehen

Soleno Therapeutics Inc Aktie (SLNO) Neueste Nachrichten

pulisher
Nov 21, 2025

Does Soleno Therapeutics Inc. (6XC) stock trade below intrinsic valueQuarterly Trade Summary & Intraday High Probability Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Wolfe Research Initiates Soleno Therapeutics (SLNO) Coverage with Outperform Rating, $75 PT, Dismisses Patient Slowdown Concerns - Insider Monkey

Nov 21, 2025
pulisher
Nov 20, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc.SLNO - PR Newswire

Nov 20, 2025
pulisher
Nov 20, 2025

Will Soleno Therapeutics Inc. stock benefit from AI adoptionJuly 2025 Weekly Recap & Accurate Buy Signal Notifications - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Why Soleno Therapeutics Inc. (6XC) stock is a strong analyst pickBond Market & Consistent Profit Trade Alerts - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Is Soleno Therapeutics Inc. stock trading near support levelsQuarterly Market Review & Step-by-Step Trade Execution Guides - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How analysts revise price targets for Soleno Therapeutics Inc. (6XC) stock2025 Key Highlights & Smart Swing Trading Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Soleno Therapeutics Inc. stock benefit from upcoming earnings reportsTrend Reversal & Safe Investment Capital Preservation Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Soleno Therapeutics Inc. (6XC) stock attract long term capital inflows2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Soleno Therapeutics Inc. stock outperform in 2025 bull market - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

(SLNO) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 15:57:35 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Soleno Therapeutics Inc. stock a bargain at current levels - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Analyzing net buyer seller activity in Soleno Therapeutics Inc.Earnings Performance Report & Accurate Buy Signal Notifications - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Real time social sentiment graph for Soleno Therapeutics Inc.July 2025 Volume & Smart Allocation Stock Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Strategies to average down on Soleno Therapeutics Inc.Portfolio Return Report & Accurate Buy Signal Notifications - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 04:05:29 - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Full technical analysis of Soleno Therapeutics Inc. stockQuarterly Market Review & Fast Gaining Stock Reports - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Wolfe Research Initiates Coverage of Soleno Therapeutics (SLNO) with Outperform Recommendation - Nasdaq

Nov 18, 2025
pulisher
Nov 18, 2025

Soleno Therapeutics Inc. (SLNO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 18, 2025
pulisher
Nov 18, 2025

Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, - GlobeNewswire

Nov 18, 2025
pulisher
Nov 18, 2025

Commit To Buy Soleno Therapeutics At $30, Earn 20.1% Annualized Using Options - Nasdaq

Nov 18, 2025
pulisher
Nov 17, 2025

Wolfe Research initiates Soleno Therapeutics stock with Outperform rating By Investing.com - Investing.com Nigeria

Nov 17, 2025
pulisher
Nov 17, 2025

Wolfe Research initiates Soleno Therapeutics stock with Outperform rating - Investing.com India

Nov 17, 2025

Finanzdaten der Soleno Therapeutics Inc-Aktie (SLNO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$38.92
price up icon 1.38%
$30.45
price up icon 1.36%
$102.06
price up icon 0.29%
$95.59
price down icon 1.42%
biotechnology ONC
$347.72
price down icon 0.45%
$198.76
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):